AI Can Be Used In the Search For Antibody Treatments
IBM hopes to make lifesaving treatments scalable and more efficient by developing an AI model for antibody treatments
IBM hopes to accelerate the development of new antibodies by using AI to produce molecules that have not been researched before
Generative AI can help candidates overcome barriers to antibody development by implementing a new series of tests outside of any individual's expertise